169 related articles for article (PubMed ID: 33306240)
21. Survival analysis of patients with stage T2a and T2b perihilar cholangiocarcinoma treated with radical resection.
Zhao J; Zhang W; Zhang J; Zhang Y; Ma WJ; Liu SY; Li FY; Song B
BMC Cancer; 2020 Sep; 20(1):849. PubMed ID: 32883228
[TBL] [Abstract][Full Text] [Related]
22. A radiomics approach to predict lymph node metastasis and clinical outcome of intrahepatic cholangiocarcinoma.
Ji GW; Zhu FP; Zhang YD; Liu XS; Wu FY; Wang K; Xia YX; Zhang YD; Jiang WJ; Li XC; Wang XH
Eur Radiol; 2019 Jul; 29(7):3725-3735. PubMed ID: 30915561
[TBL] [Abstract][Full Text] [Related]
23. Recurrence Rate and Pattern of Perihilar Cholangiocarcinoma after Curative Intent Resection.
Groot Koerkamp B; Wiggers JK; Allen PJ; Besselink MG; Blumgart LH; Busch OR; Coelen RJ; D'Angelica MI; DeMatteo RP; Gouma DJ; Kingham TP; Jarnagin WR; van Gulik TM
J Am Coll Surg; 2015 Dec; 221(6):1041-9. PubMed ID: 26454735
[TBL] [Abstract][Full Text] [Related]
24. Magnetic resonance imaging radiomics predicts preoperative axillary lymph node metastasis to support surgical decisions and is associated with tumor microenvironment in invasive breast cancer: A machine learning, multicenter study.
Yu Y; He Z; Ouyang J; Tan Y; Chen Y; Gu Y; Mao L; Ren W; Wang J; Lin L; Wu Z; Liu J; Ou Q; Hu Q; Li A; Chen K; Li C; Lu N; Li X; Su F; Liu Q; Xie C; Yao H
EBioMedicine; 2021 Jul; 69():103460. PubMed ID: 34233259
[TBL] [Abstract][Full Text] [Related]
25. Can machine learning radiomics provide pre-operative differentiation of combined hepatocellular cholangiocarcinoma from hepatocellular carcinoma and cholangiocarcinoma to inform optimal treatment planning?
Liu X; Khalvati F; Namdar K; Fischer S; Lewis S; Taouli B; Haider MA; Jhaveri KS
Eur Radiol; 2021 Jan; 31(1):244-255. PubMed ID: 32749585
[TBL] [Abstract][Full Text] [Related]
26. Prediction for early recurrence of intrahepatic mass-forming cholangiocarcinoma: quantitative magnetic resonance imaging combined with prognostic immunohistochemical markers.
Zhao L; Ma X; Liang M; Li D; Ma P; Wang S; Wu Z; Zhao X
Cancer Imaging; 2019 Jul; 19(1):49. PubMed ID: 31307551
[TBL] [Abstract][Full Text] [Related]
27. Prognostic Relevance of the Eighth Edition of TNM Classification for Resected Perihilar Cholangiocarcinoma.
Hau HM; Meyer F; Jahn N; Rademacher S; Sucher R; Seehofer D
J Clin Med; 2020 Sep; 9(10):. PubMed ID: 33003424
[TBL] [Abstract][Full Text] [Related]
28. Diagnostic and Prognostic Role of 18-FDG PET/CT in the Management of Resectable Biliary Tract Cancer.
Ma KW; Cheung TT; She WH; Chok KSH; Chan ACY; Dai WC; Chiu WH; Lo CM
World J Surg; 2018 Mar; 42(3):823-834. PubMed ID: 28905105
[TBL] [Abstract][Full Text] [Related]
29. A radiomic-based model of different contrast-enhanced CT phase for differentiate intrahepatic cholangiocarcinoma from inflammatory mass with hepatolithiasis.
Xue B; Wu S; Zhang M; Hong J; Liu B; Xu N; Zeng Q; Tang K; Zheng X
Abdom Radiol (NY); 2021 Aug; 46(8):3835-3844. PubMed ID: 33728532
[TBL] [Abstract][Full Text] [Related]
30. Long-term outcome and prognostic factors of intrahepatic cholangiocarcinoma involving the hepatic hilus versus hilar cholangiocarcinoma after curative-intent resection: Should they be recognized as perihilar cholangiocarcinoma or differentiated?
Lu J; Li B; Li FY; Ye H; Xiong XZ; Cheng NS
Eur J Surg Oncol; 2019 Nov; 45(11):2173-2179. PubMed ID: 31208772
[TBL] [Abstract][Full Text] [Related]
31. A Radiomics-based Approach for Predicting Early Recurrence in Intrahepatic Cholangiocarcinoma after Surgical Resection: A Multicenter Study.
Hao X; Liu B; Hu X; Wei J; Han Y; Liu X; Chen Z; Li J; Bai J; Chen Y; Wang J; Niu M; Tian J
Annu Int Conf IEEE Eng Med Biol Soc; 2021 Nov; 2021():3659-3662. PubMed ID: 34892030
[TBL] [Abstract][Full Text] [Related]
32. Preoperative risk factors for early recurrence after resection of perihilar cholangiocarcinoma.
Yamamoto R; Sugiura T; Ashida R; Ohgi K; Yamada M; Otsuka S; Aramaki T; Asakura K; Uesaka K
BJS Open; 2022 Sep; 6(5):. PubMed ID: 36125346
[TBL] [Abstract][Full Text] [Related]
33. Lymph node dissection in resectable perihilar cholangiocarcinoma: a systematic review.
Kambakamba P; Linecker M; Slankamenac K; DeOliveira ML
Am J Surg; 2015 Oct; 210(4):694-701. PubMed ID: 26212390
[TBL] [Abstract][Full Text] [Related]
34. Superiority of clinical American Joint Committee on Cancer T classification for perihilar cholangiocarcinoma.
Yamada M; Mizuno T; Yamaguchi J; Yokoyama Y; Igami T; Onoe S; Watanabe N; Uehara K; Matsuo K; Ebata T
J Hepatobiliary Pancreat Sci; 2022 Jul; 29(7):768-777. PubMed ID: 34717042
[TBL] [Abstract][Full Text] [Related]
35. Radiomic Features at Contrast-enhanced CT Predict Recurrence in Early Stage Hepatocellular Carcinoma: A Multi-Institutional Study.
Ji GW; Zhu FP; Xu Q; Wang K; Wu MY; Tang WW; Li XC; Wang XH
Radiology; 2020 Mar; 294(3):568-579. PubMed ID: 31934830
[TBL] [Abstract][Full Text] [Related]
36. Development and Validation of a Machine-Learning Model to Predict Early Recurrence of Intrahepatic Cholangiocarcinoma.
Alaimo L; Lima HA; Moazzam Z; Endo Y; Yang J; Ruzzenente A; Guglielmi A; Aldrighetti L; Weiss M; Bauer TW; Alexandrescu S; Poultsides GA; Maithel SK; Marques HP; Martel G; Pulitano C; Shen F; Cauchy F; Koerkamp BG; Endo I; Kitago M; Pawlik TM
Ann Surg Oncol; 2023 Sep; 30(9):5406-5415. PubMed ID: 37210452
[TBL] [Abstract][Full Text] [Related]
37. Radiomics using CT images for preoperative prediction of futile resection in intrahepatic cholangiocarcinoma.
Chu H; Liu Z; Liang W; Zhou Q; Zhang Y; Lei K; Tang M; Cao Y; Chen S; Peng S; Kuang M
Eur Radiol; 2021 Apr; 31(4):2368-2376. PubMed ID: 33033863
[TBL] [Abstract][Full Text] [Related]
38. Computed Tomography-Based Radiomics Model to Predict Central Cervical Lymph Node Metastases in Papillary Thyroid Carcinoma: A Multicenter Study.
Li J; Wu X; Mao N; Zheng G; Zhang H; Mou Y; Jia C; Mi J; Song X
Front Endocrinol (Lausanne); 2021; 12():741698. PubMed ID: 34745008
[TBL] [Abstract][Full Text] [Related]
39. The preoperative prognostic value of the radiomics nomogram based on CT combined with machine learning in patients with intrahepatic cholangiocarcinoma.
Tang Y; Zhang T; Zhou X; Zhao Y; Xu H; Liu Y; Wang H; Chen Z; Ma X
World J Surg Oncol; 2021 Aug; 19(1):45. PubMed ID: 34334138
[TBL] [Abstract][Full Text] [Related]
40. How long should follow-up be continued after R0 resection of perihilar cholangiocarcinoma?
Nakahashi K; Ebata T; Yokoyama Y; Igami T; Mizuno T; Yamaguchi J; Onoe S; Watanabe N; Nagino M
Surgery; 2020 Oct; 168(4):617-624. PubMed ID: 32665142
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
